Delivery Order SPE2DR25D7061-SPE2DR26F7WSJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,861.20 to AmerisourceBergen Drug Corp for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, issued on September 29, 2025, with a completion date of September 30, 2025, represents a non-competitive set-aside contract supporting the military's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,023.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 Tablet 21s, a contraceptive medication, valued at $10,234.79 with a firm fixed price contract type. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive delivery order. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,291.19 on September 26, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Loestrin 21 1-20 tablets (a contraceptive medication) in quantities of 21 tablets per unit. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, was competitively awarded without set-aside restrictions. The contract represents a...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency (DLA) awarded a $2,999.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Loestrin 21 1-20 tablets (21-count units). The contract, which was not set aside and competitively awarded, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,500.57 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance taking place at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $63,466.34 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages). This firm fixed-price, competitively awarded contract (with no set-aside designation) is effective through November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.56 to AmerisourceBergen Drug Corp for NORTREL 0.5-35-28 Tablet 28S, a contraceptive medication. The contract was awarded on August 14, 2025, under firm fixed-price terms with an ultimate completion date of August 15, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7WSJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,199.45 to AmerisourceBergen Drug Corp for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. Issued on December 9, 2025, with an ultimate completion date of December 10, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under the agency's medical supply chain operations. The award was made on a competitive basis with no set-aside designation, and performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/8/25 |